Five Below, Inc. Is Being Sued For Possible Securities Law Violations And Investors Are Invited To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Five Below, Inc. ("Five Below" or "the Company") (NASDAQ:FIVE) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder […]

Paragon 28, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Wants Shareholders To Lend A Hand

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) for violations of the securities laws. The investigation focuses on whether the Company issued false

MADISON AVENUE COUTURE ANNOUNCES TWO MAJOR FALL INITIATIVES: ONLINE AUCTIONS AND IN-HOME VALUATIONS

Madison Avenue Couture, the preeminent reseller of authentic rare and collectible ultra-luxury handbags, jewelry and accessories, kicks off a period of exciting expansion initiatives this fall. Judy Taylor, the company’s CEO, said “As we approach our 15th anniversary on February 1, 2025, we are committed to bringing our luxury products and high level of customer

Elanco Animal Health Incorporated Is Being Investigated For Securities Law Violations And The Schall Law Firm Invites Shareholder Participation

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false

Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And Stockholders With Losses Are Urged By The Schall Law Firm To Help

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

The Schall Law Firm Has Launched An Inquiry Into Zoetis Inc For Securities Fraud And Shareholders Are Urged To Join

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

The Schall Law Firm Is Looking Into Biomea Fusion Inc For Securities Fraud And Affected Investors Are Invited To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or "the Company") (NASDAQ:BMEA) violations of the securities laws. According to the Complaint, the Company made false and misleading statements

4D Molecular Therapeutics, Inc. Is Being Investigated For Securities Fraud And Investors Are Urged To Assist The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics" or "the Company") (NASDAQ:FDMT) for violations of the securities laws. The investigation focuses on whether the Company

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

Scroll to Top